Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11046691 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors

Patent 11046691 was granted and assigned to IDEAYA Biosciences on June, 2021 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

IDEAYA Biosciences

Current Assignee

IDEAYA Biosciences

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11046691

Date of Patent

June 29, 2021

Patent Application Number

17175578

Date Filed

February 12, 2021

Patent Citations

‌

US Patent 10532042 KRAS G12C inhibitors and methods of using the same

‌

US Patent 10329298 Inhibitors of cellular metabolic processes

‌

US Patent 10519146 KRAS G12C inhibitors and methods of using the same

‌

US Patent 10800782 Inhibitors of cellular metabolic processes

Patent Primary Examiner

‌

Emily A Bernhardt

Patent abstract

Disclosed herein are certain 2-oxoquinazoline derivatives of Formula (IA):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11046691 2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API